INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,581,000 | -4.3% | 4,926,125 | +37.3% | 0.10% | -3.8% |
| Q3 2021 | $25,687,000 | -22.5% | 3,587,636 | +0.3% | 0.10% | -23.0% |
| Q2 2021 | $33,156,000 | +11.9% | 3,576,706 | +12.1% | 0.14% | +1.5% |
| Q1 2021 | $29,618,000 | -15.0% | 3,191,675 | -19.0% | 0.13% | -22.7% |
| Q4 2020 | $34,860,000 | -11.2% | 3,939,018 | +16.4% | 0.17% | -31.2% |
| Q3 2020 | $39,243,000 | -31.2% | 3,383,001 | +59.8% | 0.25% | -39.5% |
| Q2 2020 | $57,038,000 | +112.9% | 2,116,427 | -41.2% | 0.41% | +48.0% |
| Q1 2020 | $26,790,000 | +8.5% | 3,600,798 | -51.9% | 0.28% | +38.1% |
| Q4 2019 | $24,693,000 | +81.3% | 7,482,827 | +12.6% | 0.20% | +55.4% |
| Q3 2019 | $13,617,000 | -31.2% | 6,642,546 | -1.4% | 0.13% | -32.6% |
| Q2 2019 | $19,803,000 | -9.2% | 6,735,726 | +15.2% | 0.19% | -18.9% |
| Q1 2019 | $21,815,000 | +2.2% | 5,848,410 | +9.6% | 0.24% | -16.5% |
| Q4 2018 | $21,352,000 | -19.5% | 5,337,930 | +12.0% | 0.28% | -5.9% |
| Q3 2018 | $26,509,000 | +147.0% | 4,767,879 | +74.1% | 0.30% | +134.9% |
| Q2 2018 | $10,734,000 | -11.1% | 2,738,190 | +6.8% | 0.13% | -17.3% |
| Q1 2018 | $12,073,000 | +9.7% | 2,563,279 | -3.8% | 0.16% | +6.8% |
| Q4 2017 | $11,004,000 | -35.5% | 2,664,488 | -1.0% | 0.15% | -37.1% |
| Q3 2017 | $17,063,000 | -16.6% | 2,691,331 | +3.1% | 0.23% | -18.6% |
| Q2 2017 | $20,469,000 | +70.1% | 2,610,818 | +43.6% | 0.28% | +61.0% |
| Q1 2017 | $12,032,000 | -6.0% | 1,817,512 | -1.5% | 0.18% | -8.3% |
| Q4 2016 | $12,802,000 | -26.2% | 1,844,734 | -0.9% | 0.19% | -25.2% |
| Q3 2016 | $17,350,000 | +0.1% | 1,861,553 | -0.8% | 0.26% | -2.6% |
| Q2 2016 | $17,336,000 | +6.1% | 1,876,152 | -0.9% | 0.26% | +6.0% |
| Q1 2016 | $16,340,000 | +25.5% | 1,893,355 | -2.3% | 0.25% | +38.9% |
| Q4 2015 | $13,025,000 | +17.5% | 1,938,278 | +1.1% | 0.18% | +21.6% |
| Q3 2015 | $11,086,000 | -30.7% | 1,917,910 | -2.1% | 0.15% | -14.9% |
| Q2 2015 | $15,986,000 | +2.0% | 1,959,114 | +2.0% | 0.17% | +6.7% |
| Q1 2015 | $15,678,000 | -9.8% | 1,921,310 | +1.5% | 0.16% | -9.4% |
| Q4 2014 | $17,372,000 | +1205.2% | 1,892,412 | +1300.9% | 0.18% | +1185.7% |
| Q3 2014 | $1,331,000 | +445.5% | 135,088 | +499.5% | 0.01% | +600.0% |
| Q2 2014 | $244,000 | – | 22,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |